Immunofluorescent labeling of increased calpain expression and neuronal death in the spinal cord of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice
- 1 May 2004
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 1006 (2) , 150-156
- https://doi.org/10.1016/j.brainres.2004.01.065
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Inhibition of Calpains Prevents Neuronal and Behavioral Deficits in an MPTP Mouse Model of Parkinson's DiseaseJournal of Neuroscience, 2003
- Calpain Upregulation and Neuron Death in Spinal Cord of MPTP‐Induced Parkinsonism in MiceAnnals of the New York Academy of Sciences, 2002
- Does neuronal loss in Parkinson's disease involve programmed cell death?BioEssays, 2001
- Caspase-8 Is an Effector in Apoptotic Death of Dopaminergic Neurons in Parkinson's Disease, But Pathway Inhibition Results in Neuronal NecrosisJournal of Neuroscience, 2001
- Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's diseaseProceedings of the National Academy of Sciences, 2000
- Caspase and calpain substrates: Roles in synaptic plasticity and cell deathJournal of Neuroscience Research, 1999
- The substantia nigra of the human brainBrain, 1999
- The substantia nigra of the human brainBrain, 1999
- Systemic administration of MPTP induces thalamic neuronal degeneration in miceBrain Research, 1997
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984